Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy.

Prins RM, Soto H, Konkankit V, Odesa SK, Eskin A, Yong WH, Nelson SF, Liau LM.

Clin Cancer Res. 2011 Mar 15;17(6):1603-15. doi: 10.1158/1078-0432.CCR-10-2563. Epub 2010 Dec 6.

2.

Recombinant adenovirus-transduced dendritic cell immunization in a murine model of central nervous system tumor.

Broder H, Anderson A, Odesa SK, Kremen TJ, Liau LM.

Neurosurg Focus. 2000 Dec 15;9(6):e6.

PMID:
16817689
3.

Central nervous system tumor immunity generated by a recombinant listeria monocytogenes vaccine targeting tyrosinase related protein-2 and real-time imaging of intracranial tumor burden.

Prins RM, Bruhn KW, Craft N, Lin JW, Kim CH, Odesa SK, Miller JF, Liau LM.

Neurosurgery. 2006 Jan;58(1):169-78; discussion 169-78.

PMID:
16385341
4.

Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment.

Liau LM, Prins RM, Kiertscher SM, Odesa SK, Kremen TJ, Giovannone AJ, Lin JW, Chute DJ, Mischel PS, Cloughesy TF, Roth MD.

Clin Cancer Res. 2005 Aug 1;11(15):5515-25.

6.

Immunotherapeutic targeting of shared melanoma-associated antigens in a murine glioma model.

Prins RM, Odesa SK, Liau LM.

Cancer Res. 2003 Dec 1;63(23):8487-91.

7.

MART-1 adenovirus-transduced dendritic cell immunization in a murine model of metastatic central nervous system tumor.

Broder H, Anderson A, Kremen TJ, Odesa SK, Liau LM.

J Neurooncol. 2003 Aug-Sep;64(1-2):21-30.

PMID:
12952283
8.

Tumor immunity within the central nervous system stimulated by recombinant Listeria monocytogenes vaccination.

Liau LM, Jensen ER, Kremen TJ, Odesa SK, Sykes SN, Soung MC, Miller JF, Bronstein JM.

Cancer Res. 2002 Apr 15;62(8):2287-93.

Supplemental Content

Loading ...
Support Center